The prognostic value of histopathological grading systems in oral squamous cell carcinomas

Oral Diseases

Volumn 21, Issue 6, 2015, Pages 755-761

  Sawazaki Calone, I ^a,b   Rangel, A L C A ^a   Bueno, A G ^c   Morais, C F ^d   Nagai, H M ^e   Kunz, R P ^f   Souza, R L ^a   Rutkauskis, L ^a   Salo, T ^b,g,h   Almangush, A ^g,h   Coletta, R D ^b  

^a UNIVERSIDADE ESTADUAL DO OESTE DO PARANÁ   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c ANATOM Anatomic Pathology to Laboratoy   (Brazil)

^d APC Anatomic Pathology Laboratory   (Brazil)

^e UOPECCAN Cancer Hospital   (Brazil)

^f Oncology Center of Cascavel (CEONC)   (Brazil)

^g OULU UNIVERSITY HOSPITAL   (Finland)

^h UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Histopathological grading system; Oral cancer; Oral squamous cell carcinoma; Prognosis; Survival analysis

Indexed keywords

ADULT; AGE; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; HISTOLOGICAL RISK MODEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANCY GRADING OF THE DEEP INVASIVE MARGIN; MOUTH SQUAMOUS CELL CARCINOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; REGIONAL METASTASIS; SCORING SYSTEM; TUMOR BUDDING AND DEPTH OF INVASION MODEL; WORLD HEALTH ORGANIZATION GRADING SYSTEM; AGED; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PROCEDURES; PROGNOSIS; SECONDARY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR VOLUME; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM GRADING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL RATE; TUMOR BURDEN;

EID: 84938747119     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12343     Document Type: Article

References (48)

1. Almangush A, Salo T, Hagström J, Leivo I (2014a). Tumour budding in head and neck squamous cell carcinoma-a systematic review. Histopathology 65: 587-594.
2. Almangush A, Bello IO, Keski-Säntti H et al (2014b). Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck 36: 811-818.
3. Almangush A, Coletta RD, Bello IO et al (2015). A simple novel prognostic model for early stage oral tongue cancer. Int J Oral Maxillofac Surg 44: 143-150.
4. Anneroth G, Batsakis J, Luna M (1987). Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res 95: 229-249.
5. Barnes L, Eveson JW, Reichart P, Sidransky E, eds. (2005). World Health Organization classification of tumors. Pathology and genetics of head and neck tumours. IARC Press: Lyon.
6. Brandwein-Gensler M, Teixeira MS, Lewis CM et al (2005). Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29: 167-178.
7. Brandwein-Gensler M, Smith RV, Wang B et al (2010). Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma. Am J Surg Pathol 34: 676-688.
8. Broders AC (1920). Squamous cell cancer of the lip: a study of five hundred and thirty-seven cases. JAMA 74: 656-664.
9. Bryne M, Hs K, Lilleng R, Stene T, Bang G, New DE (1989). New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas. J Oral Pathol Med 18: 432-437.
10. Bryne M, Koppang HS, Lilleng R, Kjaerheim A (1992). Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol 166: 375-381.
11. Chaudhary B, Abd Al Samid M, Al-Ramadi BK, Elkord E (2014). Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer. Expert Opin Biol Ther 14: 931-945.
12. Costa Ade L, Araújo Júnior RF, Ramos CCF (2005). Correlation between TNM classification and malignancy histological feature of oral squamous cell carcinoma. Braz J Otorhinolaryngol 71: 181-187.
13. Datema FR, Ferrier MB, Van Der Schroeff MP, De Jong RJB (2010). Impact of comorbidity on short-term mortality and overall survival of head and neck cancer patients. Head Neck 32: 728-736.
14. Dayan D, Salo T, Salo S et al (2012). Molecular crosstalk between cancer cells and tumor microenvironment components suggests potential targets for new therapeutic approaches in mobile tongue cancer. Cancer Med 1: 128-140.
15. Dissanayaka WL, Pitiyage G, Kumarasiri PVR, Liyanage RLPR, Dias KD, Tilakaratne WM (2012). Clinical and histopathologic parameters in survival of oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 113: 518-525.
16. Funk G, Karnell L, Robinson RA, Zhen WK, Trask DK, Hoffman HT (2002). Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck 24: 165-180.
17. Ganly I, Goldstein D, Carlson DL et al (2013). Long-term regional control and survival in patients with "low-risk", early stage oral tongue cancer managed by partial glossectomy and neck dissection without postoperative radiation: the importance of tumor thickness. Cancer 119: 1168-1176.
18. Gueiros LA, Coletta RD, Kowalski LP, Lopes MA (2011). Clinicopathological features and proliferation markers in tongue squamous cell carcinomas. Int J Oral Maxillofac Surg 40: 510515.
19. Hanahan D, Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell 144: 646-674.
20. Huang C-H, Chu S-T, Ger L-P, Hou Y-Y, Sun C-P (2007). Clinicopathologic evaluation of prognostic factors for squamous cell carcinoma of the buccal mucosa. J Chin Med Assoc 70: 164-170.
21. Huang SH, Hwang D, Lockwood G, Goldstein DP, O'Sullivan B (2009). Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies. Cancer 115: 1489-1497.
22. Jerjes W, Upile T, Petrie A et al (2010). Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients. Head Neck Oncol 2: 9.
23. Johnson NW, Jayasekara P, Amarasinghe AAHK (2011). Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. Periodontol 2000 57: 19-37.
24. Kantola S, Parikka M, Jokinen K et al (2000). Prognostic factors in tongue cancer - relative importance of demographic, clinical and histopathological factors. Br J Cancer 83: 614-619.
25. Kurokawa H, Zhang M, Matsumoto S et al (2005). The high prognostic value of the histologic grade at the deep invasive front of tongue squamous cell carcinoma. J Oral Pathol Med 34: 329-333.
26. Li Y, Bai S, Carroll W et al (2013). Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma. Head Neck Pathol 7: 211-223.
27. Lindenblatt RDCR, Martinez GL, Silva LE, Faria PS, Camisasca DR, Lourenço SDQC (2012). Oral squamous cell carcinoma grading systems-analysis of the best survival predictor. J Oral Pathol Med 41: 34-39.
28. López RV, Levi JE, Eluf-Neto J et al (2014). Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection. Cancer Causes Control 25: 461-471.
29. O-Charoenrat P, Pillai G, Patel S et al (2003). Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer. Oral Oncol 39: 386-390.
30. Piva MR, de Souza LB, Martins-Filho PRS, Soares RC, de Santana Santos T, de Souza Andrade ES (2011). Role of inflammation in oral carcinogenesis (Part I): histological grading of malignancy using a binary system. Oncol Lett 2: 1225-1231.
31. Platz H, Fries R, Hudec M, Min Tjoa A, Wagner RR (1983). The prognostic relevance of various factors at the time of first admission of the patient. J Maxillofac Surg 11: 3-12.
32. Po Wing Yuen A, Lam KY, Lam LK et al (2002). Prognostic factors of clinically stage I and II oral tongue carcinoma - A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features. Head Neck 24: 513-520.
33. Rodrigues PC, Miguel MCC, Bagordakis E et al (2014). Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases. Int J Oral Maxillofac Surg 43: 795-801.
34. Salo T, Vered M, Bello IO et al (2014). Insights into the role of components of the tumor microenvironment in oral carcinoma call for new therapeutic approaches. Exp Cell Res 325: 58-64.
35. Sarioglu S, Acara C, Akman FC et al (2010). Tumor budding as a prognostic marker in laryngeal carcinoma. Pathol Res Pract 206: 88-92.
36. Sarkaria JN, Harari PM (1994). Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapy. Head Neck 16: 107-111.
37. Sawair FA, Irwin CR, Gordon DJ, Leonard AG, Stephenson M, Napier SS (2003). Invasive front grading: reliability and usefulness in the management of oral squamous cell carcinoma. J Oral Pathol Med 32: 1-9.
38. Silveira EJD, Godoy GP, Lins RDAU et al (2007). Correlation of clinical, histological, and cytokeratin profiles of squamous cell carcinoma of the oral tongue with prognosis. Int J Surg Pathol 15: 376-383.
39. Sinha P, Mehrad M, Chernock RD et al (2015). Histologic and systemic prognosticators for local control and survival in margin negative transoral laser microsurgery-treated oral cavity squamous cell carcinoma. Head Neck 37: 52-63.
40. Son YH, Kapp DS (1985). Oral cavity and oropharyngeal cancer in a younger population. Review of literature and experience at Yale. Cancer 55: 441-444.
41. Teramoto H, Koike M, Tanaka C et al (2013). Tumor budding as a useful prognostic marker in T1-stage squamous cell carcinoma of the esophagus. J Surg Oncol 108: 42-46.
42. Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC (2002). Tumour "budding" as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40: 127-132.
43. Vered M, Dobriyan A, Dayan D et al (2010a). Tumor-host histopathologic variables, stromal myofibroblasts and risk score, are significantly associated with recurrent disease in tongue cancer. Cancer Sci 101: 274-280.
44. Vered M, Dayan D, Dobriyan A et al (2010b). Oral tongue squamous cell carcinoma: recurrent disease is associated with histopathologic risk score and young age. J Cancer Res Clin Oncol 136: 1039-1048.
45. Wang C, Huang H, Huang Z et al (2011). Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. J Oral Pathol Med 40: 545-551.
46. Weijers M, Snow GB, Bezemer PD, van der Waal I (2009). Malignancy grading is no better than conventional histopathological grading in small squamous cell carcinoma of tongue and floor of mouth: retrospective study in 128 patients. J Oral Pathol Med 38: 343-347.
47. Woolgar JA (2006). Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol 42: 229-239.
48. Yamaguchi Y, Kojima M, Yoh K, Otsuka H, Nagai K, Ochiai A (2010). Histopathologic Features of the Tumor Budding in Adenocarcinoma of the Lung. J Thorac Oncol 5: 1361-1368.